Sun Pharmaceutical has received USFDA approval for Elepsia XR, an antiepileptic drug in US markets. The company has received this approval through one of its subsidiaries. The drug Elepsia XR in the strengths of 1,000 mg and 1,500 mg, is likely to be manufactured from its Halol (Gujarat) manufacturing facility.
Company Profile : Sun Pharmaceutical Industries Ltd
Leave a Reply